BIO · ISSUER CIK 12208
BIO-RAD LABORATORIES, INC.
Between Aug 1, 2026 and Oct 29, 2026, 9 BIO-RAD LABORATORIES, INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗9 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 27, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 202616:57 | Oct 24, 2026 | BIO | President & COO | M · Exercise | — | +1,869 | 3,832 | +95% | — | ||
| Oct 27, 202616:57 | Oct 24, 2026 | BIO | President & COO | F · Tax | $369.95 | −951 | 2,881 | -25% | $352K | ||
| Oct 22, 202617:55 | Oct 20, 2026 | BIO | EVP, Global Supply Chain | M · Exercise | — | +1,044 | 4,647 | +29% | — | ||
| Oct 22, 202617:55 | Oct 20, 2026 | BIO | EVP, Global Supply Chain | F · Tax | $354.50 | −487 | 4,160 | -10% | $173K | ||
| Sep 9, 202618:47 | Sep 6, 2026from Sep 5, 2026 | BIO | Director | M · Exercise | — | +320 | 1,768 | +22% | — | ||
| Sep 9, 202618:47 | Sep 6, 2026from Sep 5, 2026 | BIO | Director | F · Tax | $386.11 | −116 | 1,734 | -6% | $45K | ||
| Sep 9, 202618:46 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, President, LSG | M · Exercise | — | +2,083 | 2,495 | +506% | — | ||
| Sep 9, 202618:46 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, President, LSG | F · Tax | $386.11 | −839 | 2,025 | -29% | $324K | ||
| Sep 9, 202618:46 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, Global Supply Chain | M · Exercise | — | +1,891 | 3,880 | +95% | — | ||
| Sep 9, 202618:46 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, Global Supply Chain | F · Tax | $386.11 | −606 | 3,603 | -14% | $234K | ||
| Sep 9, 202618:45 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, President, CDG | M · Exercise | — | +2,179 | 2,313 | +1626% | — | ||
| Sep 9, 202618:45 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, President, CDG | F · Tax | $386.11 | −854 | 1,828 | -32% | $330K | ||
| Sep 9, 202618:45 | Sep 5, 2026 | BIO | President & COO | M · Exercise | — | +1,712 | 2,631 | +186% | — | ||
| Sep 9, 202618:45 | Sep 5, 2026 | BIO | President & COO | F · Tax | $386.11 | −668 | 1,963 | -25% | $258K | ||
| Sep 9, 202618:45 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, General Counsel & Sec | M · Exercise | — | +1,453 | 1,957 | +288% | — | ||
| Sep 9, 202618:45 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, General Counsel & Sec | F · Tax | $386.11 | −551 | 1,652 | -25% | $213K | ||
| Sep 9, 202618:44 | Sep 5, 2026 | BIO | EVP, GBL Commercial Operations | M · Exercise | — | +1,826 | 1,736 | — | — | ||
| Sep 9, 202618:44 | Sep 5, 2026 | BIO | EVP, GBL Commercial Operations | F · Tax | $386.11 | −737 | 1,232 | -37% | $285K | ||
| Sep 9, 202618:42 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, Chief Financial Officer | M · Exercise | — | +2,906 | 4,933 | +143% | — | ||
| Sep 9, 202618:42 | Sep 6, 2026from Sep 5, 2026 | BIO | EVP, Chief Financial Officer | F · Tax | $386.11 | −1,341 | 4,151 | -24% | $518K | ||
| Sep 9, 202618:42 | Sep 6, 2026from Sep 5, 2026 | BIO | Chairman & CEO, Director, 10% Owner | M · Exercise | — | +7,564 | 450,873 | +2% | — | ||
| Sep 9, 202618:42 | Sep 6, 2026from Sep 5, 2026 | BIO | Chairman & CEO, Director, 10% Owner | F · Tax | $386.11 | −4,730 | 449,019 | -1% | $1.8M | ||
| Sep 3, 202617:41 | Sep 1, 2026 | BIO | EVP, President, LSG | M · Exercise | — | +425 | 935 | +83% | — | ||
| Sep 3, 202617:41 | Sep 1, 2026 | BIO | EVP, President, LSG | F · Tax | $380.96 | −154 | 781 | -16% | $59K | ||
| Sep 3, 202617:38 | Sep 1, 2026 | BIO | Director | M · Exercise | — | +117 | 1,573 | +8% | — | ||
| Sep 3, 202617:38 | Sep 1, 2026 | BIO | Director | F · Tax | $380.96 | −43 | 1,530 | -3% | $16K | ||
| Sep 3, 202617:35 | Sep 1, 2026 | BIO | Chairman & CEO, Director, 10% Owner | M · Exercise | — | +5,087 | 448,521 | +1% | — | ||
| Sep 3, 202617:35 | Sep 1, 2026 | BIO | Chairman & CEO, Director, 10% Owner | F · Tax | $380.96 | −2,336 | 446,185 | -1% | $890K |